Supplements and Featured Publications
Optimizing Outcomes in Venous Thromboembolism Among Hospitalized Medically Ill Patients Through an Integrated Risk Assessment Program
Role of the Bruton Tyrosine Kinase Pathway in Multiple Sclerosis
Volume: 28
Issue: 16
The Evidence for Semaglutide 2.4 mg in Obesity From a Managed Care Perspective
Volume: 28
Issue: 15
Digital Health Solutions in Chronic Illnesses: An AJMC® Scientific Interchange
Rethinking Heart Failure: Patient Classification and Treatment
Volume: 28
Issue: 14
Microinjection via the Suprachoroidal Space: A Review of a Novel Mode of Administration
Volume: 28
Issue: 13
Biosimilars for Immune-Mediated Inflammatory Diseases: 2022 Update
Volume: 28
Issue: 12
Exclusive Coverage of the European Society for Medical Oncology Congress 2022
Coverage of the European Society for Medical Oncology Congress 2022, which took place in a virtual format and in person in Paris, France.
A Population Health Approach to Managing Heart Failure
Best Practices and Future Opportunities in Care Delivery for Severe, Uncontrolled Asthma: an AJMC® Profiles in Care
Uncovering the Economic Burden of Chronic Cough and the Promising Role of Emerging Targeted Therapies
Volume: 28
Issue: 9
The Impact of PCSK9 Modulation on Cardiovascular Outcomes: Recent Advances and the Managed Care Implications
Volume: 28
Issue: 8
Emerging Care Management Strategies for Severe Asthma: Integrating Biologic Therapy
Volume: 28
Issue: 11
Advancing Alzheimer Disease Treatment: Updates and Insights for Managed Care Professionals
Volume: 28
Issue: 10
VIVJOA™ (OTESECONAZOLE) CLINICAL MONOGRAPH
Improving HER2 Biomarker Testing in Metastatic Colorectal Cancer
The Evolving Landscape of Demodex Blepharitis Management
The Clinical and Economic Benefits Associated With Novel Multi-Cancer Early Detection Tests: Conference Highlights from the 2022 ISPOR Annual Meeting
Volume: 28
Issue: 7
Variations in Managing Chronic Kidney Disease Associated With Type 2 Diabetes Across the United States and Validation of the FINE-CKD Model for Future Health Technology Assessments of Finerenone
Volume: 28
Issue: 6
Updates and Evolving Treatment Strategies in Acute Myeloid Leukemia
Issue: 1 Suppl
Disease Burden of Relapsing-Remitting Multiple Sclerosis
Oncology Care Pathways Supporting the Use of High-value Treatments for NSCLC
Implementing the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure: SGLT2 Inhibitors, Treatment Sequencing, and Value Statements
Uptake of Oncology Biosimilars: Managed Care Strategies to Improve Value-Based Care Systems
Volume: 28
Issue: 5
Analyzing the Value of Continuous Glucose Monitoring in Diabetes Care and Overcoming Barriers Through Expanded Pharmacy Access
Volume: 28
Issue: 4
The Role of Real-World Evidence, Patient-Reported Outcomes, and Economic Models in Oncology Formulary Decisions and the Role of Real-World Evidence in Oncology Product Registration
Management of Interstitial Lung Disease: Emerging Therapies and Unmet Needs
Role of Real-World Evidence in the Evolving Treatment Landscape of Multiple Myeloma
ZEPOSIA® (ozanimod), a Sphingosine 1-Phosphate Receptor Modulator for Relapsing Forms of Multiple Sclerosis
Clinical Trial Data Can Be Supplemented by Real-World Evidence: An Example for an Oral Anticoagulant in Patients With Nonvalvular Atrial Fibrillation at Risk of Stroke
Advertisement
Advertisement
Trending on AJMC
1
Bills to Address Expiring ACA Subsidies Fail to Pass Senate
2
Advancing Early Detection and Equitable Access in Alzheimer Disease Care
3
ICYMI: Highlights From SPD 2025
4
In CLL, New Therapies Offer Potential for Personalized Approaches
5
